Skip to the reading

Care decisions begin with clear questions

Irvine Peptide Clinic

An Irvine starting path, one stage after another. Nobody prescribes from this site.

Back to the starting path
A quiet stucco courtyard with a shaded arch and drought-tolerant planting.

The California checks that come first

Your location during care matters. Use the California rules to ask precise questions before agreeing to a visit.

Check the clinician and the pharmacy separately. Each has its own public record and responsibilities.

On this page

Use your location during the visit

Telehealth means care through a remote connection. The Medical Board’s guidance checked September 28, 2026 requires a current California license for doctors treating someone in California that way; living in the state is not required.

Source: State remote-care rules

That distinction matters when you compare a local office with a remote service. Ask where you must be when the visit takes place. If travel is coming up, raise that before scheduling. Do not assume that a visit arranged from home can happen from anywhere. Put the location question beside the professional’s full name and license type, so the service can answer it directly.

Expect a conversation about consent

Under California law checked September 28, 2026, the professional initiating telehealth must describe its use, obtain spoken or written consent, and document that consent.

Source: State consent rule

The same law preserves the option of in-person care during a course of treatment after someone agrees to telehealth.

Source: State consent rule

Consent is your agreement to that way of receiving care. Ask what the remote visit can cover and how a change to an in-person setting would work. If the explanation is unclear, ask for it again in ordinary words. A form can record an agreement, but your questions still deserve an answer.

An online form is not the whole rule

California allowed a self-screening tool or questionnaire for an assessment before prescribing, under the law checked September 26, 2026. The person assessing you still had to meet the care standard: gather enough information about your health to make the care decision properly for your case. How much assessment is needed depends on the individual case. Ask how the reviewer learns enough about your symptoms and history to decide what care is appropriate.

Source: State prior-exam law

So the mere presence of a form does not settle whether a service is doing an adequate assessment.

Source: State prior-exam law

Ask who reviews what you send, how that person asks for more detail, and how your questions reach the person reviewing the form. Keep a copy of the exchange if the service offers one. Read the telehealth notes for a fuller account of live and delayed conversations.

Look up the pharmacy as well

The California rule checked September 28, 2026 requires an out-of-state pharmacy shipping prescription medicines into the state to hold a California nonresident pharmacy license.

Source: State pharmacy rule

For sterile compounded drugs, a separate California sterile compounding license is also required for an out-of-state pharmacy sending them into California, under the law checked September 2026.

Source: State sterile-drug law

Sterile means free of living germs. Ask the service for the actual pharmacy name, then use the pharmacy board’s lookup. Do not substitute the telehealth brand for the name of the business that would make the medicine.

Keep state permission in perspective

A California pharmacy license does not turn a compounded drug into an FDA-approved product; FDA’s September 2026 position is that compounded drugs are not approved.

Source: FDA on medicine preparation

FDA is short for Food and Drug Administration. Before approving a particular medicine, the agency reviews evidence about its benefits, its risks, and how well it is made. A state license and a product’s approval answer separate questions. Take both into the discussion. If someone gives a broad answer such as everything here is permitted, ask which rule supports the exact product being proposed. The useful next step is an answer about that product, not a general assurance about peptide care.